Siminder Kaur Atwal

Siminder Kaur Atwal is an experienced clinical development professional currently serving as Executive Director of Clinical Development at Prelude Therapeutics since May 2022. Prior to this role, Atwal held key positions at Fate Therapeutics Inc as Senior Director of Clinical Development and at BeiGene, where Atwal advanced from Senior Clinical Scientist to Director of Clinical Science. Atwal's career also includes significant roles at Genentech, AstraZeneca, Covance Central Laboratory Services SA, The Institute of Cancer Research, and the University of Leicester. Siminder Kaur Atwal earned a Ph.D. in Oncology and Cancer Biology from the University of Leicester, highlighting a strong academic foundation in the field.